Spotlight
Clinical Role
Clinical
Supplement Spotlight
CE
Subscribe
Press Release
Article
Camber Launches Generic Neurontin®
Key Takeaways
- Camber Pharmaceuticals introduces Gabapentin Oral Solution, expanding its existing gabapentin product offerings.
- Indications include management of postherpetic neuralgia in adults and adjunctive therapy for partial onset seizures in patients aged three and older.
Piscataway, NJ, October 25, 2024 – Camber Pharmaceuticals is pleased to announce the addition of Gabapentin Oral Solution to its product line. Camber also offers Gabapentin Tablets and Capsules.
Image credit: Camber Pharmaceuticals Inc.
Gabapentin Oral Solution is indicated for:
- Management of Postherpetic Neuralgia in adults
- Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy
Gabapentin Oral Solution is available in a 470 mL bottle with a concentration of 250 mg per 5 mL.
To learn more about Gabapentin Oral Solution, please visit https://www.camberpharma.com/gabapentinoralsolution
Related Videos
Related Content
